Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$16.1M Buy
420,900
+26,200
+7% +$1.06M 0.01% 1096
2014
Q2
$16M Sell
394,700
-31,900
-7% -$1.31M 0.01% 1016
2014
Q1
$17.5M Buy
426,600
+148,400
+53% +$5.65M 0.02% 877
2013
Q4
$10.6M Buy
278,200
+26,177
+10% +$900K 0.01% 1209
2013
Q3
$8.36M Buy
252,023
+36,423
+17% +$1.18M 0.01% 1267
2013
Q2
$6.62M Buy
+215,600
New +$7.15M 0.01% 1373

Other funds holding ORCL

UBS's ORCL Position: Q3 2014 in Review

UBS reduced its Oracle (ORCL) stake by 1.5% in Q3 2014, selling an estimated $3.21M and leaving 5,238,395 shares worth $201M. The position accounts for 0.15% of the portfolio, ranked #152.

UBS first reported a position in ORCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $216M in Q2 2014. 1,498 funds tracked by Wall St. Rank hold ORCL as of Q3 2014.

  • UBS held 5,238,395 shares of Oracle worth $201M as of Q3 2014.
  • UBS sold 79,405 Oracle shares in Q3 2014, an estimated $3.21M.
  • Oracle made up 0.15% of UBS's portfolio in Q3 2014, its #152 holding.
  • UBS first reported a position in Oracle in Q2 2013 and has held it in 6 quarters since.
  • UBS's Oracle position peaked at $216M in Q2 2014.
  • 1,498 funds tracked by Wall St. Rank held Oracle as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.